Masanori Mori, Julian Sprague. Show Affiliations »
Abstract
Entities: Chemical Disease Gene Species
Mesh: See more » Abnormal KaryotypeAntineoplastic Agents/therapeutic useBenzenesulfonates/therapeutic useCytogenetic AnalysisDrug Resistance, Neoplasm/drug effectsErythroid Cells/pathologyFemaleGene DuplicationHumansLeukemia, Erythroblastic, Acute/drug therapyLeukemia, Erythroblastic, Acute/geneticsMiddle AgedNiacinamide/analogs & derivativesPhenylurea CompoundsPyridines/therapeutic useRemission InductionSorafenibTandem Repeat Sequences/geneticsTandem Repeat Sequences/physiologyTime FactorsTreatment Outcomefms-Like Tyrosine Kinase 3/genetics
Substances: See more » Antineoplastic AgentsBenzenesulfonatesPhenylurea CompoundsPyridinesNiacinamideSorafenibFLT3 protein, humanfms-Like Tyrosine Kinase 3
Year: 2011 PMID: 21996560 DOI: 10.1016/j.leukres.2011.09.023
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156